Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Methylphenidate and 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') are widely misused psychoactive drugs. Methylphenidate increases brain dopamine and norepinephrine levels by blocking the presynaptic reuptake transporters. MDMA releases serotonin, dopamine and norepinephrine through the same transporters. Pharmacodynamic interactions of methylphenidate and MDMA are likely. This study compared the pharmacodynamic and pharmacokinetic effects of methylphenidate and MDMA administered alone or in combination in healthy subjects using a double-blind, placebo-controlled, crossover design. Methylphenidate did not enhance the psychotropic effects of MDMA, although it produced psychostimulant effects on its own. The haemodynamic and adverse effects of co-administration of methylphenidate and MDMA were significantly higher compared with MDMA or methylphenidate alone. Methylphenidate did not change the pharmacokinetics of MDMA and vice versa. Methylphenidate and MDMA shared some subjective amphetamine-type effects; however, 125 mg of MDMA increased positive mood more than 60 mg of methylphenidate, and methylphenidate enhanced activity and concentration more than MDMA. Methylphenidate and MDMA differentially altered facial emotion recognition. Methylphenidate enhanced the recognition of sad and fearful faces, whereas MDMA reduced the recognition of negative emotions. Additionally, the present study found acute pharmacodynamic tolerance to MDMA but not methylphenidate. In conclusion, the combined use of methylphenidate and MDMA does not produce more psychoactive effects compared with either drug alone, but potentially enhances cardiovascular and adverse effects. The findings may be of clinical importance for assessing the risks of combined psychostimulant misuse. Trial registration identification number: NCT01465685 (http://clinicaltrials.gov/ct2/show/NCT01465685).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychometric evaluation of the altered states of consciousness rating scale (OAV)
Studerus, E., Gamma, A., & Vollenweider, F. X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012412 · Cited by 683 · cited 1×
“The 5-Dimensions of Altered States of Consciousness Rating Scale (5D-ASC; Studerus et al., 2010) was used 5 h after MDMA/placebo administration to retrospectively rate the effects of the drugs.”
MethodKuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623 · cited 2×
“, 2003), NE (Kuczenski and Segal, 1997) and 5-HT (Blardi et al.”
BackgroundProcessing of facial emotion expression in major depression: a review
Bourke, C., Douglas, K., & Porter, R. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.496359 · Cited by 557
Liechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00148-7 · Cited by 248 · cited 6×
“Overall, the available data indicate that the SERT and NET mediate most of the acute effects of MDMA, but the role of DA remains unclear.”
BackgroundInfluentialSelf-citationBedi, G., Hyman, D., & de Wit, H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.003 · Cited by 247 · cited 2×
“We used a previously described Facial Emotion Recognition Task that is sensitive to MDMA (Bedi et al., 2010).”
MethodResultDextroamphetamine modulates the response of the human amygdala
Hariri, A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00373-1 · Cited by 185 · cited 1×
“Thus, methylphenidate tended to produce negative bias in emotional information processing, similar to the DA/NE releaser D-amphetamine (Hariri et al., 2002; Wardle et al., 2012).”
BackgroundA review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
Dumont, G. J. H., & Verkes, R. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063271 · Cited by 149 · cited 2×
“MDMA but not methylphenidate increased plasma cortisol and D ow nloaded from https://academ ic.oup.com /ijnp/article-abstract/17/3/371/758860 by guest on 10 April 2019 prolactin concentrations as expected (Weizman et al., 1987; Upadhyaya et al., 2003; Dumont and Verkes, 2006).”
BackgroundMDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions
Hysek, C. M., Domes, G., & Liechti, M. E. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2645-9 · Cited by 144
Self-citation
Research works printed but not linked: 35
- 10.1177/0269881107083639 · DOI · Paper page
- 10.1007/s00213-012-2708-y · DOI · Paper page
- 2007, Psychopharmacol, 189, 489
- 10.1021/ac4004584 · DOI · Paper page
- 2003, Psychopharmacol (Berl), 166, 95, 10.1007/s00213-002-1303-z · DOI
- 2012, Front Genet, 3, 1
- 10.1124/jpet.104.067116 · DOI · Paper page
- 10.1016/j.drugalcdep.2005.09.003 · DOI
- 1994, Eur J Clin Pharmacol, 46, 441, 10.1007/BF00191908 · DOI
- 10.1159/000084163 · DOI
- 10.1016/0893-133X(95)00117-V · DOI
- 2013, Neuropsychopharmacol, 38, 1079
- 1963, Br Med Bull, 19, 132, 10.1093/oxfordjournals.bmb.a070031 · doi:10.1093/oxfordjournals.bmb.a070031
- 10.1002/syn.20804 · DOI
- 10.1176/appi.ajp.163.7.1149 · doi:10.1176/appi.ajp.163.7.1149 · Paper page
- 10.1038/sj.npp.1300979 · DOI · Paper page
- 10.1111/j.1360-0443.2005.00944.x · DOI · Paper page
- 1971, Clin Pharmacol Ther, 12, 245, 10.1002/cpt1971122part1245 · DOI · Paper page
- 10.1177/026988110001400313 · DOI · Paper page
- 10.1016/j.biopsych.2012.04.005 · DOI · Paper page
- 1978, Die Eigenschaftswörterliste
- 2003, Psychopharmacol (Berl), 166, 264, 10.1007/s00213-002-1340-7 · DOI
- 10.1097/JCP.0b013e3182979d32 · DOI · Paper page
- 10.1124/jpet.111.188425 · DOI
- 10.1111/j.1476-5381.2012.01936.x · DOI · Paper page
- 10.1038/clpt.2011.78 · DOI · Paper page
- 10.1007/s00213-012-2761-6 · DOI
- 1976, Die Beschwerden-Liste. Münchener Informationssystem
- 10.1186/1471-2210-6-6 · DOI · Paper page
- 10.1016/j.pbb.2006.06.023 · DOI
- 10.1124/jpet.107.129056 · DOI
- 10.1111/j.1465-3362.2011.00324.x · DOI
- 10.1007/s00213-009-1545-0 · DOI
- 10.1016/0024-3205(87)90060-9 · DOI
- 1995, J Clin Endocrinol Metab, 80, 3009
Cited by
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
“…5-HT releaser, MDMA, has marked pro-social, pro-empathy, antiaggressive effects during the acute phase (Bedi et al., 2010, 2014; Frye et al., 2014; Hysek et al., 2012, 2014a; Kamboj et al., 2015; Kirilly et al., 2006; Schmid et al., 2014; Stewart et al., 2014), perhaps via an inhibitory action on…”
BackgroundPsychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., Kalin, N. H., McDonald, W. M., & and the Work Group on Biomarkers and Novel Treatments, A. D. O. T. A. P. A. C. O. R. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19010035 · Cited by 649
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.015 · Cited by 411
Self-citationDanforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., Yazar-Klosinski, B., & Emerson, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5010-9 · Cited by 280
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.82 · Cited by 247
“…et al, 2010; Hysek et al, 2014b), increased explicit and implicit emotional empathy on the MET (Hysek et al, 2014a; Kuypers et al, 2014) (mainly for positive emotionally charged situations) (Hysek et al, 2014a; Schmid et al, 2014), and increased prosociality on the SVO test (Hysek et al, 2014a).”
InfluentialSelf-citation
Metadata
- Authors
- Hysek, C. M., Simmler, L. D., Schillinger, N., Meyer, N., Schmid, Y., Donzelli, M., Grouzmann, E., & Liechti, M. E.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-08
- Volume
- 17
- Issue
- 03
- Pages
- 371-381
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2007520100
- Cited by
- 126
- References
- 8
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. https://app.cochat.ai/papers/10.1017/s1461145713001132
- The paper
- Hysek, C. M., Simmler, L. D., Schillinger, N., Meyer, N., Schmid, Y., Donzelli, M., Grouzmann, E., & Liechti, M. E. (2014). Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145713001132
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.